Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 10
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Preference Study With Elderly Patients Recurrent Ovarian Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
70 and over
Other
3401000
NCT00170690
2.
Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other, Pharmaceutical / Industry
101.321-13/07
EudraCT Nr. 2008-001686-28, NCT00779714
3.
Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 to 65
Other
OSHO #071
NCT00384553
4.
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 65
Other
2003.332
NCT00129155
5.
Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-Refractory Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
CSTI571BDE59
NCT00427999
6.
Treosulfan-Based Conditioning for Transplantation in AML/MDS
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 68
Other
SHEBA-07-3116-AN-CTIL
NCT00491634
7.
Study of Metastatic Ocular Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
Haema CBF AHM UK/AS 04
NCT00168870
8.
Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 69
Other
2005-005182-11
NCT00598624
9.
Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 65
Other
TreoALL
NCT00682305
First Published:
11/20/2008
10.
Phase II Study of Reduced-Intensity Conditioning Comprising Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Patients With Hematological Malignancies Undergoing Umbilical Cord Blood Transplantation From an Unrelated Donor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Under 65
NCI
FHCRC-2275.00
FHCRC-2275.00, IR-6800, NCT00796068
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute